Skip to content

Anatomical Femoral Stem in Total Hip Arthroplasty

Short Term Results of Short Anatomical Femoral Stem in Total Hip Arthroplasty - Prospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04243980
Acronym
THR
Enrollment
50
Registered
2020-01-28
Start date
2020-02-01
Completion date
2022-01-01
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Compliance, Patient Satisfaction

Brief summary

A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side

Interventions

DEVICEShort anatomical femoral stem in THR

Patients with osteoarthritis after total hip arthroplasty

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* age 18-90 * patients who had THR as an elective surgery * patients who had THR with short femoral anatomical stem

Exclusion criteria

* severe osteoporosis with Dorr C classification * s/p bilateral hip arthroplasty * non-complaint patients * revision surgery

Design outcomes

Primary

MeasureTime frameDescription
Femoral anteversionPost-Operatively, through study completion, an average of 2 yearscomparing femoral anteversion after THR using CT scan

Secondary

MeasureTime frameDescription
Harris Hip Score6 weeks, 3 month, 6 month post-operativeThe HHS is a physician-completed instrument that consists of subscales for pain severity (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 0-4 points), and range of motion (2 items, 0-5 points). Where a score \< 70 indicating a poor result and those of 90-100 indicating an excellent result

Contacts

Primary ContactRaja Hakim, M.D.
raja.hakim@icloud.com00972546612251

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026